Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mackett

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
The Journal of General Virology|February 1, 1992
Protective immunization against Epstein-Barr virus-induced disease in cottontop tamarins using the virus envelope glycoprotein gp340 produced from a bovine papillomavirus expression vectorS Finerty, J Tarlton, M Mackett, et al.
Virology|August 1, 1993
The Epstein-Barr virus candidate vaccine antigen gp340/220 is highly conserved between virus types A and BJ F Lees, J E Arrand, S D Pepper, et al.
Journal of Medical Virology|November 1, 1996
Immunisation of common marmosets with vaccinia virus expressing Epstein-Barr virus (EBV) gp340 and challenge with EBVM Mackett, C Cox, S D Pepper, et al.
European Journal of Immunology|March 1, 1989
Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoproteinM Hany, S Oehen, M Schulz, et al.
The Journal of General Virology|September 18, 1997
The processing, transport and heterologous expression of Epstein-Barr virus gp110M A Papworth, A A Van Dijk, G R Benyon, et al.
International Immunology|May 1, 1993
MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathwaysS P Lee, L E Wallace, M Mackett, et al.
Journal of Virology|September 1, 1994
Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptideJ N Flynn, C A Cannon, J A Beatty, et al.
Microbes and Infection|January 4, 2001
Vaccinia expression of Mycobacterium tuberculosis-secreted proteins: tissue plasminogen activator signal sequence enhances expression and immunogenicity of M. tuberculosis Ag85A S Malin, K Huygen, J Content, et al.
Journal of Medical Virology|May 1, 1993
Expression of human papillomavirus type 16 E7 protein by recombinant baculovirus and use for the detection of E7 antibodies in sera from cervical carcinoma patientsS N Stacey, A Ghosh, J S Bartholomew, et al.
The Journal of General Virology|June 1, 1997
Genetic content and preliminary transcriptional analysis of a representative region of murine gammaherpesvirus 68M Mackett, J P Stewart, S de V Pepper, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
The Journal of General Virology|February 1, 1992
Protective immunization against Epstein-Barr virus-induced disease in cottontop tamarins using the virus envelope glycoprotein gp340 produced from a bovine papillomavirus expression vectorS Finerty, J Tarlton, M Mackett, et al.
Virology|August 1, 1993
The Epstein-Barr virus candidate vaccine antigen gp340/220 is highly conserved between virus types A and BJ F Lees, J E Arrand, S D Pepper, et al.
Journal of Medical Virology|November 1, 1996
Immunisation of common marmosets with vaccinia virus expressing Epstein-Barr virus (EBV) gp340 and challenge with EBVM Mackett, C Cox, S D Pepper, et al.
European Journal of Immunology|March 1, 1989
Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoproteinM Hany, S Oehen, M Schulz, et al.
The Journal of General Virology|September 18, 1997
The processing, transport and heterologous expression of Epstein-Barr virus gp110M A Papworth, A A Van Dijk, G R Benyon, et al.
International Immunology|May 1, 1993
MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathwaysS P Lee, L E Wallace, M Mackett, et al.
Journal of Virology|September 1, 1994
Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptideJ N Flynn, C A Cannon, J A Beatty, et al.
Microbes and Infection|January 4, 2001
Vaccinia expression of Mycobacterium tuberculosis-secreted proteins: tissue plasminogen activator signal sequence enhances expression and immunogenicity of M. tuberculosis Ag85A S Malin, K Huygen, J Content, et al.
Journal of Medical Virology|May 1, 1993
Expression of human papillomavirus type 16 E7 protein by recombinant baculovirus and use for the detection of E7 antibodies in sera from cervical carcinoma patientsS N Stacey, A Ghosh, J S Bartholomew, et al.
The Journal of General Virology|June 1, 1997
Genetic content and preliminary transcriptional analysis of a representative region of murine gammaherpesvirus 68M Mackett, J P Stewart, S de V Pepper, et al.
Pageof 6